These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet; 1998 Nov; 352(9139):1498-504. PubMed ID: 9820297 [TBL] [Abstract][Full Text] [Related]
10. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
11. A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG). Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH Mult Scler; 1995 Jun; 1(2):118-35. PubMed ID: 9345462 [TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group. J Neurol Neurosurg Psychiatry; 1989 May; 52(5):566-74. PubMed ID: 2659737 [TBL] [Abstract][Full Text] [Related]
19. The placebo effect during a double blind trial of recombinant alpha 2 interferon in multiple sclerosis patients: immunological and clinical findings. Hirsch RL; Johnson KP; Camenga DL Int J Neurosci; 1988 Apr; 39(3-4):189-96. PubMed ID: 3045033 [TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS. Lancet; 1998 Nov; 352(9139):1491-7. PubMed ID: 9820296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]